Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Recent Moves By Pfizer Management: No Big Deal Or Telegraphing A Sell-Off?
Seeking Alpha
Wednesday, December 18, 2013 - 8:20am
tags:
Pfizer
Will GSK's Sales And Marketing Changes Result In Lower Revenues?
Forbes
Wednesday, December 18, 2013 - 8:19am
tags:
GSK
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting
Seeking Alpha
Wednesday, December 18, 2013 - 8:18am
tags:
melanoma, Amgen, Inovio, OncoSec Medical, TVEC
Novartis Needs Special Delivery for Potent Cell Therapy
Bloomberg
Wednesday, December 18, 2013 - 8:16am
tags:
Novartis, cancer cell therapy, CTL019
Pfizer, Teva reach deal to allow launch of generic Viagra by 2017
Yahoo/AP
Tuesday, December 17, 2013 - 3:02pm
tags:
Generic, Viagra, Pfizer, Teva, erectile dysfunction
FDA Puts Out Warning on J&J, Novartis ADHD Drugs
Wall St Cheat Sheet
Tuesday, December 17, 2013 - 3:01pm
tags:
JNJ, FDA, ADHD, Novartis, methylphenidate, Ritalin, Concerta
NeoStem: Final Data Is Just Around the Corner
Wall St Cheat Sheet
Tuesday, December 17, 2013 - 2:44pm
tags:
NeoStem, AMR-001
European Drug Agency Delays Trial-Data Policy Until March
Bloomberg
Tuesday, December 17, 2013 - 2:36pm
tags:
clinical trial data, EMA, Europe
Agenus: How Meaningful Is The Prophage Phase II Data?
Seeking Alpha
Tuesday, December 17, 2013 - 2:35pm
tags:
Agenus, Prophage, glioblastoma
Boehringer's blood clot drug shows promise in broader use trial
Yahoo/Reuters
Tuesday, December 17, 2013 - 10:58am
tags:
Boehringer Ingelheim, Pradaxa, blood thinners
Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
Motley Fool
Tuesday, December 17, 2013 - 10:42am
tags:
Biogen Idec, JNJ, Merck, Bravecto, animal health, Samsung, Hospira, Amgen, AbbVie, anti-TNF
Pfizer’s Schulman to Leave as Head of New Drug Unit
Bloomberg
Tuesday, December 17, 2013 - 10:39am
tags:
Pfizer, Amy Schulman, consumer health, vaccines, oncology
Decision Diagnostics Receives Mandate From U.S. Court of Appeals for the Federal Circuit in the Long Running Dispute With J&J Division
Yahoo
Tuesday, December 17, 2013 - 10:34am
tags:
Decision Diagnostics, JNJ, patents, diagnostics, Shasta GenStrip, Lifescan Ultra
Pfizer's R&D Chief On How Drug Research Is Evolving
Forbes
Tuesday, December 17, 2013 - 9:43am
tags:
Pfizer, R&D
Biogen Idec preps for a big leap into the anti-TNF blockbuster biosimilars market
Fierce Biotech
Tuesday, December 17, 2013 - 9:39am
tags:
Biogen Idec, anti-TNF, Samsung Bioepis, Samsung, biosimilars
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Yahoo/Fly on the Wall
Tuesday, December 17, 2013 - 9:37am
tags:
Amgen, evolocumab, cholesterol
Biodel up 10.5 percent premarket after supply agreement with Becton Dickinson
Reuters
Tuesday, December 17, 2013 - 9:35am
tags:
Biodel, Becton Dickinson
Pharma gets social: Top-10 pharma social media firsts in 2013
Pharmaforum
Tuesday, December 17, 2013 - 9:02am
tags:
social media
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
Bloomberg
Tuesday, December 17, 2013 - 8:57am
tags:
Arimidex, AstraZeneca, breast cancer
Roche Share Discount Widens on Bet Novartis to Sell Stake
Bloomberg
Tuesday, December 17, 2013 - 8:56am
tags:
Roche, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.